Average Co-Inventor Count = 5.68
ph-index = 11
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vertex Pharmaceuticals, Inc. (26 from 1,149 patents)
2. Takeda San Diego, Inc. (1 from 53 patents)
28 patents:
1. 8691848 - Inhibitors of caspases
2. 8618152 - Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases
3. 8338412 - Inhibitors of P38
4. 8119631 - Inhibitors of interleukin-1β converting enzyme
5. 8002891 - Crystallization of C-Jun N-Terminal Kinase 3 (JNK3)
6. 7951809 - Inhibitors of p38
7. 7790713 - Inhibitors of interleukin-1β converting enzyme
8. 7527952 - Crystals of inosine monophosphate dehydrogenase/oxidized inosine monophosphate thiomidate intermediate/mycophenolic acid (IIMPDH/XMP*/MPA)
9. 7507552 - Crystallization of histone deacetylase 2
10. 7383135 - Methods of designing inhibitors for JNK kinases
11. 7365072 - Inhibitors of p38
12. 7358273 - Inhibitors of caspases
13. 7216041 - Methods of using the structure coordinates of molecules comprising an IMPDH-like binding pocket
14. 7205305 - Inhibitors of p38
15. 7065452 - Molecules comprising a calcineurin-like binding pocket and encoded data storage medium capable of graphically displaying them